Agenda

11:30 a.m. - 1:00 p.m.
Lunch Buffet
12:15 p.m. - 1:15 p.m.
Welcome and Regional Update
By Regina Butler, RN-BC , Lisa Maiale-Howell, MSS, LCSW
1:15 p.m. - 2:45 p.m.
Part II: Is Emicizumab for Everyone? The Pros and Cons of Emicizumab Use
By Justin Schofield , Kathaleen M. Schnur, LSW , Leslie Raffini, M.D. , Elaine Chiang, M.D. , Regina Butler, RN-BC , Chris Guelcher, MS, APRN, PPCNP-BC , Jan Kuhn, BSN
2:45 p.m. - 3:00 p.m.
Research Highlight: Emicizumab Prophylactic Therapy in Patients with Hemophilia A
By Erika J. Martin, MT (ASCP)
3 p.m. - 3:30 p.m.
Break
3:30 p.m. - 5:00 p.m.
Breakout Sessions